TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT06414824

The isCGM Use and Hypoglycemic Episodes and Fear of Hypoglycemia in Newly Diagnosed Type 1 Diabetes

Cause of deathSlow enrollment Automatic label, confidence 0.5, unverified. How labels are made.
“The study ended early due to CGM reimbursement policy changes, after that most patients eligible for the study could have isCGM reimbursed.”

The sponsor’s own words in the registry.

Life of this trial

2022202320242025Started2022-05-01Primary completion2023-12-31Registered2024-05-10Stopped2024-05-31

Vital statistics

Status
Terminated
Phase
Na
Sponsor
Jagiellonian University
Sponsor type
University, hospital or other
Conditions
Diabetes Mellitus, Type 1
Interventions
Intermittently Scanned Continuous Glucose Monitoring; Standard Blood Glucose Monitoring
Participants
28
Sites
4
Countries
Poland

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.